U.S. STEM CELL, INC.

SUNRISE, FL – September, 1st, 2022 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solution...

https://us-stemcell.com/wp-content-uploads-2021-10-animal-health-press-release-final-pdf-2-2/

SUNRISE, FL – March 9th, 2022 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions has...

https://us-stemcell.com/wp-content-uploads-2021-10-animal-health-press-release-final-pdf-2/

SUNRISE, FL – Oct 18th, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions will...

https://us-stemcell.com/wp-content-uploads-2021-10-animal-health-press-release-final-pdf/

SUNRISE, FL – June. 8th, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a corporation that has historically focused on the regenerative medicine / cellular therapy industry specializing in physicia...

https://us-stemcell.com/us-stem-cell-inc-reports-legal-appeal-results-and-company-direction/

SUNRISE, FL – Feb 23, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce

https://us-stemcell.com/wp-content-uploads-2021-02-northstar-usrm-press-release-2021_final-1-pdf/

SUNRISE, FL – Jan 19, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce

https://us-stemcell.com/usrm-oral-argument-in-appeal-from-fda-enforcement-action/

SUNRISE, FL – Sep. 30, 2020 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce

https://us-stemcell.com/corrected-usrm-posts-earnings-for-second-quarter-2019-2/

Dear Shareholders and Friends, Thank you for your continued interest and support in U.S. Stem Cell, Inc.  In an effort to keep you updated on matters related to the Company,

https://us-stemcell.com/ceo-blog-a-summary-of-recent-events/

SUNRISE, FL – August 7, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, tod...

https://us-stemcell.com/corrected-usrm-posts-earnings-for-second-quarter-2019/

SUNRISE, FL – August 7, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, tod...

https://us-stemcell.com/usrm-posts-earnings-for-second-quarter-2019/